Use: This test is intended to be used as an aid to the diagnosis of human granulocytic anaplasmosis (HGA), a condition formerly known as human granulocytic ehrlichiosis (HGE) caused by Anaplasma phagocytophilum.

Limitations:This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.

Methodology: Polymerase chain reaction (PCR)